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We introduce a Bayesian prior distribution, the Logit-
Normal continuous analogue of the spike-and-slab
(LN-CASS), which enables flexible parameter estima-
tion and variable/model selection in a variety of set-
tings. We demonstrate its use and efficacy in three case
studies – a simulation study and two studies on real
biological data from the fields of metabolomics and
genomics. The prior allows the use of classical statis-
tical models, which are easily interpretable and well-
known to applied scientists, but performs comparably
to common machine learning methods in terms of gen-
eralisability to previously unseen data.
I. INTRODUCTION
Often in real-world regression problems, we are faced
with a situation in which we have a large number of
potentially irrelevant predictors, possibly even greater
than the number of observations. This so-called p  n
problem is especially prevalent in the biological and
medical sciences with the advent of high-throughput ex-
perimental methods and an increasing focus on synthe-
sising knowledge of molecular details into models pre-
dicting much lower-dimensional observable outcomes.
Regularisation and shrinkage methods aim to reduce
the influence of the inherent noise in such problems and
provide sparse estimated parameter vectors, essentially
performing simultaneous variable selection and param-
eter fitting. The motivation is two-fold. Firstly, regu-
larisation aims to more robustly distinguish strong from
weak effects, i.e. more reliably identify the genuine driv-
ing forces of the process of interest. Secondly, we wish
to reduce overfitting to improve the generalisability of
our models. The performance of our method in both of
these respects is demonstrated below.
The most common means of dealing with the p  n
problem is the LASSO1,2, whose ability to induce gen-
uine sparsity (i.e. estimates of exactly zero) and whose
computationally efficient implementation make it at-
tractive for general-purpose regularised regression. A
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number of Bayesian analogues of the LASSO and other
penalised likelihood methods have been proposed in or-
der to more fully account for the uncertainty in param-
eter estimates, which we contend is particularly impor-
tant in small n/large p problems, and to tackle the ten-
dency of the LASSO to underestimate large effects3–5.
Some authors have focused on the subset of such
problems in which the predictors have a known group-
ing structure, for example in problems from genetics
in which the groups correspond to known regulatory
networks6. This has led to the development of both
penalised likelihood7 and Bayesian8,9 modifications of
common shrinkage methods.
In this paper, we present a new shrinkage prior –
the Logit-normal continuous analogue of the spike-and-
slab (LN-CASS) – based on a Logit-Normal relaxation
of the Bernoulli distribution used in the spike-and-slab
prior10. The spike-and-slab is considered the gold-
standard of Bayesian variable selection11, but is compu-
tationally intractable in practice due to its combinatorial
complexity.
The LN-CASS prior has the advantage that its intu-
itive formulation allows it to be simply extended to al-
most any hierarchical situation – two of which are cov-
ered below – allowing the modeller to tailor the spec-
ifications of common statistical models to favour ‘sim-
pler’ models in a variety of senses. Below we struc-
ture our models to favour first homogeneous groups of
predictors before allowing within-group heterogeneity
(simulation study) and to favour purely linear effects
before nonlinear effects (metabolomics study), as well
as applying the method in its simplest form to shrink
logistic regression coefficients (microarray case study).
The Bayesian formalism ‘allows the data to decide’ the
appropriate level of complexity through the likelihood
function.
In the simulation study, the LN-CASS prior empiri-
cally appears robust to group misspecification, and out-
performs the horseshoe prior3, the LASSO1 and the
sparse group LASSO7. Additionally, we apply the LN-
CASS prior to a real-life classification task, in which
we aim to distinguish benign from malignant adrenal
tumours. Our method leads to an out-of-sample pre-
dictive performance comparable to state-of-the-art ma-
chine learning methods, but offers more interpretable
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results. We also use the method to build a predic-
tive model of colon cancer malignancy using the well-
known Colon dataset12. The code is available as a col-
lection of R functions (see Data Accessibility).
II. RESULTS
To illustrate the utility of the LN-CASS prior, we
conducted three comparative studies with the inten-
tion of assessing its two primary functions: identifica-
tion of genuinely non-zero effects and improving out-
of-sample performance by reducing overfitting. Ad-
ditionally, we chose two of the three settings to high-
light the flexibility of the approach, in particular its ca-
pacity to include known group structure (simulation,
section C.1) and to perform nonparametric regression
(metabolomics, section C.2). These two extensions are
by no means exhaustive, but are illustrative of the myr-
iad possible areas of application (see Discussion).
A. The LN-CASS Prior
We now provide a brief outline of the LN-CASS prior.
Mathematical details are available in section 1 of the
Electronic Supplementary Material (ESM).
The fundamental motivation for developing the LN-
CASS prior is to provide a computationally tractable al-
ternative to the theoretical gold-standard of Bayesian
variable selection, the spike-and-slab prior.
The spike-and-slab prior is based on the simple idea
that, a priori, we believe each parameter has some non-
zero probability of being zero, and the rest of the proba-
bility mass is assigned to other plausible parameter val-
ues (often uniformly). This hard zero/non-zero distinc-
tion introduces a discrete component into our prior be-
liefs and renders the practical use of the prior combi-
natorially intractable – we need to visit 2p parameter
combinations in order to adequately cover the param-
eter space where p is the number of parameters in our
model. For even moderately sized problems, this com-
plexity renders the spike-and-slab impractical. Indeed,
this combinatorial complexity is the same problem faced
by the frequentist ’best subset selection’, in which every
possible subset of parameters is compared and the best
performing subset is chosen.
By constructing a fully continuous approximation to
the mixed spike-and-slab prior, we enable greatly im-
proved sampling efficiency at the cost of relaxing the
hard distinction between zero and non-zero parameters.
The LN-CASS prior accomplishes this relaxation by re-
placing the discrete Bernoulli distribution in the mixture
formulation of the spike-and-slab with a Logit-normal
distribution (see the sections 1 & 2 of the ESM for de-
tails). The Logit-normal distribution, with suitable pa-
rameter choices, is a U-shaped distribution on (0, 1), as-
signing most of its mass to values close to the endpoints
(figure 1). The reason for choosing the Logit-Normal
distribution for this purpose over the similar and more
common Beta distribution is that it can be expressed
as a transformation of standard normal random vari-
ables, which greatly aids the convergence properties of
our sampler. Indeed, models can be specified purely in
terms of parameters with (conditionally) standard nor-
mal prior distributions.
We interpret the values of the Logit-normal random
variable as approximate variable inclusion probabili-
ties, which allows simple propagation of these proba-
bilities through a hierarchical prior structure. For ex-
ample, in the simulation study below we impose a hier-
archical prior structure in which we favour first exclu-
sion of whole groups of variables, then allow inclusion
of groups with a shared parameter, and finally allow
groups with differing parameters. In the metabolomics
case study below, we utilise this prior structure to
favour linear effects first, before allowing non-linear ef-
fects if the data support such effects strongly enough.
This corresponds to imposing a hierarchy on the com-
plexity of the model and allows us to refine exactly how
we control model complexity.
B. Performance measures
The main measure of performance we employ is the
area under the Receiver Operating Characteristic (ROC)
curve (AUC). The ROC curve is a plot of the false-
positive rate (specificity) against the true-positive rate
(sensitivity) as the probability threshold for classifying
a prediction as positive or negative is varied. The AUC
is interpretable as the probability of successfully dis-
tinguishing a positive result from a negative result, i.e.
the probability of correctly assigning a larger predicted
value to a positive case than a negative case. An AUC
of 0.5 corresponds to a model that simply uses the class
proportions as a prediction, while an AUC of 1 corre-
sponds to a classifier which perfectly distinguishes pos-
itive and negative cases at some threshold. We use the
AUC to quantify the trade-off between false- and true-
positives in two settings. Firstly, in the simulation study
the AUC is used to quantify the degree to which each
method uncovers the correct ordering of ground-truth
parameter values – the degree to which genuinely small
parameters are estimated to be small, and large param-
eters to be large. In this first case, positive and negative
results are related to the sparsity pattern of the ground-
truth parameter values: if a parameter has a non-zero
ground truth value, it is assigned a positive result, other-
wise it is assigned a negative result. The AUC, therefore,
measures the probability that truly non-zero parameters
are estimated to be larger (in absolute value) than truly
zero parameters. Secondly, in the metabolomics and mi-
croarray case studies, we use the AUC in the more con-
ventional setting of quantifying the out-of-sample per-
formance of a classifier.
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FIG. 1: (a) The Logit-Normal distribution with µ = 0 and σ given by (blue, orange, green) = (2.5, 5, 50). (b) The
LN-CASS priors induced by the Logit-Normal distributions of (a).
To quantify the agreement between the estimated and
true parameters in the simulation study, we use the
mean absolute error (MAE). The MAE is simply the av-
erage distance of the estimated from the true parame-
ters.
C. Applications
We now present the results of three case studies to
evaluate the comparative ability of the LN-CASS prior
to perform its two main duties – sparse parameter esti-
mation and improving out of sample performance. In
the first case study, we attempt to recover ground-truth
parameters in a simulation study in which we impose a
known grouping structure in the predictors. In the sec-
ond case study, we use real-world metabolomics data13
to build a predictive model of adrenal tumour malig-
nancy. In the third, we apply the LN-CASS prior in
the context of Bayesian logistic regression to the well-
known colon cancer dataset12.
1. Simulation Study (grouped predictors)
The motivation for this case study is to illustrate the
ability of the LN-CASS prior to penalise not only model
complexity in terms of the number of parameters, but
also the granularity of the model. Such a formulation
might be applied when there is some ‘subset’ or ‘tree-
like’ structure in the predictors. For example, in im-
munological applications, cell subsets are often nested
– T-cells are subdivided into CD4+ and CD8+ T-cells,
which in turn are subdivided into naive and memory
subsets. The grouped LN-CASS prior favours within
group homogeneity, essentially favouring less granular
models, i.e. a model using total T-cell counts would be
favoured over a model using CD4+ and CD8+ subsets
as predictors.
We generated a simulated dataset of n = 100 observa-
tions from the linear regression model
yi = β0 +Xiβ+ εi, (1)
for three different settings with grouped predictors, i.e.
where pre-specified groups share mostly the same or
similar parameter values (table 1, ESM). The matrix X
was sampled from a Unit Latin Hypercube. The εi were
chosen to be i.i.d. zero-mean Gaussian.
We then fit the model in R with the following methods
for each of the three settings (p = 20, 70, 120): Group
LN-CASS, LASSO, Horseshoe, Sparse Group LASSO
and Ordinary Least Squares. Ordinary least squares was
tested only for the p < n cases because the problem is
not well-defined when p > n. For code see Data Ac-
cessibility. Details of the grouped LN-CASS prior are
available in section 2.1 of the ESM, and full details of all
methods can be found in the code (see Data Accessibil-
ity).
LN-CASS substantially outperforms all of the other
methods in recovering the ground-truth parameters and
correctly identifying zero parameters (figure 2).
2. Steroid metabolomics and adrenal tumour malignancy
(hierarchical GAM)
We applied a hierarchical version of the LN-CASS
prior to clinical data regarding the concentrations of
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HS LASSO LN-CASS OLS SGL
MAE AUC MAE AUC MAE AUC MAE AUC MAE AUC
p = 20 0.196 1 0.223 0.99 0.043 1 0.317 1 0.643 0.95
p = 70 0.111 0.98 0.13 0.941 0.017 1 0.22 0.94 0.31 0.791
p = 120 0.096 0.9755 0.075 0.9702 0.015 1 NA NA 0.145 0.7
(c)
FIG. 2: Agreement between ground truth and estimated parameters for the simulation study in the (a) p = 120 case
(b) p = 70 case; (c) performance measures for each method. Acronyms: HS – Horseshoe; OLS – Ordinary Least
Squares; SGL – Sparse Group LASSO
metabolites in the urine of patients with two different
adrenal tumours. The task was to predict the tumour
type based on the metabolites, and to do this we used a
generalised additive model (GAM) with logit link. The
implementation of the prior in a hierarchical fashion
here was strongly inspired by a recent paper by Griffin
and Brown14.
The GAM we implemented represented the effect of
each covariate as the sum of linear basis functions. We
imposed a hierarchy through the LN-CASS prior which
favoured firstly the complete removal of a covariate
from the model, then inclusion of a purely linear effect,
and finally allowed each of the basis functions to be used
to construct a non-linear effect (for details, see the ESM,
subsection 2.2).
The dataset consisted of 158 measurements of 32
covariates13 collected as part of the EURINE-ACT study,
with 45 positive cases (malignant adrenal tumours). All
of the covariates are measurements of steroid concentra-
tions in urine samples taken from each of the patients.
There is a small proportion of missing data (up to 7% of
a covariate’s measurements), which we imputed via the
mice() function in R15. We then log(1+ x) transformed
all of the data because many of the predictors spanned
several orders of magnitude. We subsequently scaled all
covariates to lie in the interval [0, 1].
We compared the classification performance of our hi-
erarchical GAM with the performance of the following
methods: Support Vector Machine (SVM), neural net-
work (NN), random forest (RF) and elastic net (a mod-
ified version of the LASSO). Classification performance
was measured using the mean AUC over 16× 10−fold
cross-validated runs. The results are presented in fig. 3
(a).
All of the methods perform comparably in terms of
out-of-sample predictive performance, with the neural
network performing the best and LN-CASS second in
terms of both the mean and variability (inter-quartile
range) of cross-validated AUCs. The authors are not
aware of an appropriate and well-established statisti-
cal test to formalise the comparative performances of
each method given the unequal variances, clear non-
normality, and obvious dependency between samples
for a given method. However, the Kruskal-Wallis test
with a post hoc Dunn test (and appropriate multiplicity
correction) provides a non-parametric test for stochastic
dominance (i.e. the tendency of values from one distri-
bution to be larger than values from the other). We used
two multiplicity corrections, both of which account for
positive dependency (i.e. the tendency of large AUCs
to be correlated within cross-validation folds). Using
the Benjamini-Hochberg16 correction, the only null hy-
potheses to be rejected at 95% significance levels were
that the distribution of AUCs for the neural network
stochastically dominates those for the Elastic Net and
the Random Forest (adjusted p-values 0.0344 and 0.0203,
respectively). Using the Benjamini-Yekutieli17 correc-
tion, no null hypotheses were rejected; that is, no signifi-
cant differences were found between the distributions in
terms of stochastic dominance. Note that the Benjamini-
Yekutieli correction allows for arbitrary dependencies.
The results suggest that the out-of-sample perfor-
mance of the hierarchical GAM with LN-CASS prior is
comparable with that of state-of-the-art machine learn-
LN-CASS 5
0.979 0.983
0.968 0.975 0.968
0.7
0.8
0.9
1.0
LN-CASS NN RF SVM Elastic Net
Method
A
U
C
(a)
0.0
2.5
5.0
7.5
10.0
0.00 0.25 0.50 0.75 1.00
X
f i(
X
)
Covariates
All other
THS
a.cortolone
5PD
5aTHA
5PT
(b)
FIG. 3: Metabolomics case study. (a) Boxplots of AUCs for each method computed via 16× 10-fold cross-validation;
(b) estimated mean functions fi from the LN-CASS hierarchical GAM. Functions have been smoothed for
presentation purposes with a LOESS smoother using a small span.
ing methods. We argue that this performance, in con-
junction with the accuracy with which LN-CASS re-
covers ‘true’ parameters and offers more classically in-
terpretable results make it a valuable addition to the
shrinkage and regularisation toolbox for applied scien-
tists.
The recovered effects for each of the metabolites are
presented in fig. 3 (b), as estimated from the full dataset.
Clearly, the dominant predictor is THS which is in agree-
ment with the original study, as are the influential roles
of both 5PD and 5PT. We believe that the ability of the
hierarchical GAM to produce plots such as these consti-
tutes a considerable advantage over the machine learn-
ing methods tested and highlights the ability of LN-
CASS to generate not only strong predictive models, but
to be used as an exploratory tool for the generation of
hypotheses for future study.
D. Microarray data
The final case study we conducted focused on the
well-known Colon dataset of Alon et al.12. The dataset
consists of measurements of the expression levels of
2000 genes in 62 subjects, with the response variable be-
ing an indicator of Colon cancer incidence, represent-
ing a typical p  n problem in the biological/medical
sciences. We compared the performance of logistic re-
gression, with LN-CASS priors on the coefficients, to
LASSO, Random Forest and Neural Network classifiers.
We performed leave-one-out cross-validation (LOOCV)
and computed the AUC across the left out samples in or-
der to compare the estimated out-of-sample predictive
accuracy of each method. In order to reduce the bias of
the AUC estimates, we randomly removed an observa-
tion of the opposite class in each fold so that the class
proportions were identical across folds. Code to repro-
duce the results of this section is available in Data Ac-
cessibility and contains details of the particular imple-
mentations of all algorithms used.
We preprocessed the data by first log-transforming
and subsequently standardising (i.e. subtracting the
mean and dividing by the standard deviation) the ex-
pression level of each gene. We then screened the genes
via a preliminary Wald test and selected the 500 genes
with the largest Z-scores in absolute value, leaving us
with a predictor matrix consisting of the expression lev-
els of 500 genes in 62 tissues which acted as the input to
all subsequent models.
The pooled LOOCV AUCs for each method were as
follows: LN-CASS, 0.904; Neural Network, 0.8898; Ran-
dom Forest, 0.8892; LASSO, 0.858. LN-CASS performs
the best, but again all of the methods perform well and
there is not a substantial difference between the esti-
mated out-of-sample performance of each method.
Interestingly, there is some biological evidence for
class-mislabelling, i.e. samples being incorrectly marked
as either tumour or healthy12,18 in the colon dataset. Ac-
cording to Bootkrajang & Kaba´n18, there are nine such
samples. Figure 4 shows the mean posterior prediction
for each subject with these ‘suspicious’ subjects circled.
Clearly, there is reasonable agreement based on a vi-
sual inspection of the plot between the potentially mis-
labelled samples and those suggested by visual inspec-
tion of the LN-CASS model predictions. This suggests
a possible secondary function of the LN-CASS prior in
identifying mislabelled samples, the details however are
left to future work.
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FIG. 4: Mean predictions and observed outcomes from
the LN-CASS model for the microarray data. Circled
points have been identified as potentially mislabelled
by12,18
III. DISCUSSION
We have presented a new prior distribution for per-
forming regularisation/shrinkage in a Bayesian frame-
work. We have shown that its ability to produce gener-
alisable predictive models is comparable to state-of-the
art machine learning methods on two datasets of biolog-
ical interest. Additionally, we have demonstrated with
a simulation study the ability of our method to recover
ground-truth parameters, even when the number of pa-
rameters is larger than the number of datapoints. In this
regard, the performance of the LN-CASS prior is consid-
erably better than other regularisation/shrinkage meth-
ods which aim to estimate the parameters of classical,
generative probability models (linear regression, logis-
tic regression etc.).
We believe that, combined, these two properties of the
LN-CASS prior make it a worthwhile addition to the
toolboxes of applied scientists working with typical bi-
ological datasets.
Our prior requires the choices of three hyperparam-
eters, although we contend that they are much more
interpretable than those required for other Bayesian
shrinkage methods (see the ESM sections 1 & 2 for fur-
ther detail on the roles of the hyperparameters). The
three hyperparameters required correspond to, firstly,
the standard deviation of the ‘slab’ component, which
we refer to as τ; for standardised predictors, a default
value of τ = 5 has been sufficient for all of our appli-
cations because it essentially provides a vague Gaussian
prior for non-zero coefficients. Secondly, the parame-
ters of the Logit-Normal distribution (fig. 1 (a)) must
be specified; we refer to these parameters as µλ and
σλ. µλ can be chosen based on our prior beliefs about
the probability of a zero coefficient, and in our experi-
ence does not require much tuning; the median of the
Logit-Normal distribution is given by sigm(µλ), where
sigm(·) is the logistic sigmoid function. Thus, if we be-
lieve a priori that each coefficient has a probability a of
being non-zero, we simply set µλ = logit(a). σλ simply
controls the quality of the approximation to the spike-
and-slab prior, with larger values corresponding to bet-
ter approximations. We have used a default value of
σλ = 10 throughout the paper; results are not sensitive
to increases in this value.
The final key advantage of the LN-CASS prior is the
ease with which it generalises to problems with a hi-
erarchical complexity structure. This allows finer con-
trol of what exactly we mean by a ‘complex’ model,
and what we mean by a desirable model – our exam-
ple of using a generalised additive model for studying
the metabolomics data above illustrates this point. In
that case, we imposed a hierarchical complexity struc-
ture: no effect→ linear effect→ nonlinear effect. In the
simulation study, we favoured a complexity structure:
no effect → shared group effect → individual effect.
These hierarchies are accomplished simply by propa-
gating the value of the Logit-Normal random variable
through each layer and taking its product with a new
Logit-Normal random variable.
We note that the prior is particularly amenable to
problems in which a hierarchical complexity structure
is desired, by which we mean problems in which sim-
pler models are nested within more complex models.
The simplest case is the domain of the majority of the
shrinkage/regularisation literature: models with fewer
parameters are nested within models with more param-
eters. However, there are other problems with simi-
lar properties; linear models are nested within nonlin-
ear models, models with some predictors sharing coef-
ficients are nested within models in which each predic-
tor has its own coefficient. One possible area of appli-
cation is in multi-state survival modelling. Multi-state
models describe transitions between disease states by
distinct hazard functions, which may be difficult to fit
with a small sample size. One might expect that the ef-
fects of many covariates remain fairly similar regardless
of the state, for example age. Thus the LN-CASS prior
could be used to introduce a ‘soft’ constraint, encour-
aging but not enforcing covariates to share a parameter
across hazard functions. This would essentially involve
placing a grouped LN-CASS prior on the regression co-
efficients (as in the simulation study), with the groups
corresponding to covariate effects.
As with most Bayesian methods, the main obstacle to
the implementation of this methodology is the compu-
tational burden of MCMC sampling. Recent develop-
ments have made this procedure much more straight-
forward to implement and much faster19,20. However,
for large problems this computational burden is likely to
be too large to compete with the much faster frequentist
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and machine learning methods available. Approximate
Bayesian methods offer more computationally tractable
alternatives to MCMC sampling, and would be an in-
teresting avenue of future research for this problem and
allow its scalability to very large problems. In partic-
ular, nonparametric variational inference21 appears to
be the most reasonable direction, since it is able to deal
both with multimodal posterior distributions and non-
conjugate prior distributions.
One concern with spike-and-slab type inference pro-
cedures is the presence of multi-modal posterior dis-
tributions and the subsequent difficulty of some sam-
plers to sample effectively from the posterior distribu-
tion, due to them becoming ‘stuck’ in local modes. We
checked that the sampler we employed was able to ef-
fectively explore multi-modal posterior distributions in
a linear model with interactions, a problem that is par-
ticularly prone to multi-modal posteriors. We found
that whenever multi-modal posteriors appeared, they
were effectively explored by multiple MCMC chains,
and the Gelman-Rubin statistic22 revealed that samples
were consistent across chains. Section 4 of the ESM and
the accompanying code provide more details.
The LN-CASS method does not inherently provide
‘hard’ variable selection, i.e. completely removing vari-
ables from the model, in the ilk of the LASSO. We ad-
vocate using the full model (i.e. including all predic-
tors) for making predictions wherever possible, and us-
ing the absolute values of estimated parameters as vari-
able importance measures for identifying the most im-
portant predictors for the purposes of hypothesis gen-
eration and/or obtaining biological insight. However,
particularly in clinical/diagnostic circumstances, hard
variable selection is useful to reduce the burden on clin-
icians/diagnosticians in collecting relevant data for util-
ising the model at the point of care.
A variety of applicable procedures for hard variable
selection in Bayesian shrinkage models are available in
an excellent review by Vehtari et al.23. One particularly
simple method is to specify a threshold on the absolute
values of the median parameters, i.e. discard all predic-
tors whose absolute value is below some threshold. This
threshold could be chosen based on the predictive per-
formance of submodels containing only the predictors
corresponding to the largest k coefficients in absolute
value – one simply evaluates the predictive performance
of each submodel and specifies a percentage of the max-
imum (i.e. the model including all variables) to retain.
To summarise, we have presented a flexible tool for
performing regularised Bayesian regression in a variety
of settings, which allows one to construct (with relative
ease) problem-specific penalties on model complexity.
The performance on out-of-sample data is typically at
least as good as state-of-the-art methods, but the prior
allows the use of classical statistical models which can
be interpreted simply by applied biomedical scientists.
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